Novartis Pharmaceuticals UK LimitedUK Head OfficeFrimley Business Park FrimleyCamberley Surrey GU16 7SR
+44 1276 692255+44 1276 692508Monday - Friday,8:30 - 17:30
Novartis International AGInvestor RelationsP.O. BoxCH-4002 BaselSwitzerland
+41 61 324 79 email@example.com
Novartis UK Press OfficePress Office enquiries only
+44 1276 firstname.lastname@example.org
Report a suspected side effect (also known as an adverse event) related to a Novartis Pharmaceutical drug or a Novartis Vaccine.
We're looking for individuals who aspire to deliver outstanding results for both our business and for patients ... is that you? Learn more here. ..........................................................................
Listen to Vicky's story. She's recently joined our team of Key Account Managers and shares her initial experiences and thoughts on joining Novartis.
The campaign aims to raise awareness of Advanced breast cancer and the realities of living with the disease, in order to improve the level of care and support available.
A new report published today sets out six key challenges faced by those living with chronic spontaneous urticaria (CSU) and those responsible for its diagnosis and management.
Novartis announces portfolio transformation, focusing company on leading businesses with innovation power and global scale: Pharmaceuticals, Eye Care and Generics
Following the announcement in February of the closure of the Horsham site, we provide an update on proposed plans for the site here.
Adverse event reporting
Product Information Leaflets (PILs) for patients
Summary of Product Characteristics (SPC) for Healthcare Professionals